Category: Inside BIO Industry Analysis
BIO’s Dave Thomas Talks VC Funding with Daniel Levine
Last week, BIO Industry Analysis’s Dave Thomas spoke with Daniel Levine for his weekly podcast, …
BIO Accepting Nominations for its Award Honoring One Outstanding Woman in Industrial Biotech
Today, BIO announced that it has officially extended its deadline for the Rosalind Franklin Award for …
Nasdaq Social Bell: Twitter Strategies For Biotechs
Last week at the BIO CEO & Investor Conference in New York City, I had …
Deal Structures: More Options for Companies
By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal …
Ten Years of Therapeutic Venture Capital
What therapeutic areas have received the most funding in private drug companies over the last …
Forbes Asks: Should Economists Perform Surgery and Doctors Conduct Economic Policy?
Over at Forbes, University of Chicago economist Tomas Philipson has an insightful post analyzing several …
Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey
Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …
Exclusive FDA Survey Webinar
BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development. …
The Eyes Have It According to Recent VC Funding Patterns
A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …
Back to School: Consider a STEM Career
With school resuming for many throughout the country this week, one question that may be …